Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus

Annals of Anatomy

Volumn 190, Issue 3, 2008, Pages 238-245

  Cimpean, Anca Maria ^a   Raica, Marius ^a   Encica, Svetlana ^b   Cornea, Remus ^c   Bocan, Viorica ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Niculae Stancioiu Heart Institute   (Romania)

^c Clinic Hospital Nr 1   (Romania)

Author keywords

Epithelial cells; Human thymus; Thymoma; VEGF; VEGFR 1 and 2

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; HEMOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LYMPH FOLLICLE; LYMPHOCYTE DEPLETION; MALE; MYASTHENIA GRAVIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYMOMA; THYMUS DISEASE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; REFERENCE VALUES; THYMECTOMY; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 43449093422     PISSN: 09409602     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aanat.2007.05.003     Document Type: Article

References (35)

1. Blackburn C.C., and Manley N.R. Developing a new paradigm for thymus organogenesis. Nat. Immunol. 4 (2004) 278-289
2. De Gramont A., Tourniqand C., Andre T., Larsen A.K., and Louvet C. Targeted agents for adjuvant therapy of colon cancer. Semin. Oncol. 33 (2006) 42-45
3. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
4. Fan F., Wey J.S., McCarty M.F., Belcheva A., Liu W., and Bauer T.W. Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells. Oncogene 24 (2005) 2647-2653
5. Ferrara N., and Henzel W.J. Pituitary follicular cells secrete a novel heparin binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161 (1989) 851-858
6. Fukata S., Inoue K., and Kamada M. Levels of angiogenesis and expression of angiogenesis related genes are prognostic for organ-specific metastasis of renal cell carcinoma. Cancer 103 (2005) 931-942
7. Galizia G., Lieto E., and Ferraracco F. Determination of molecular marker expression can predict clinical outcome in colon carcinomas. Clin. Cancer Res. 10 (2004) 3490-3499
8. Green M.M., Hiley C.T., Shanks J.H., Bottomley I.C., West C.M., Cowan R.A., and Stratford I.J. Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int. J. Radiat. Oncol. Biol. Phys. 67 (2007) 84-90
9. Hale L.P. Histology and molecular assessment of the thymus. Ann. Diagn. Pathol. 8 (2004) 50-60
10. Hicklin D.J., and Ellis L.M. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J. Clin. Oncol. 23 (2005) 1011-1027
11. Huh J.-I., Calvo A., Stafford J., Cheung M., Kumar R., Philip D., Kleinman H.K., and Green J.E. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3 (1) Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanism. Oncogene 24 (2005) 790-800
12. Joory K.D., Levick J.R., Mortimer P.S., and Bates D.O. Vascular endothelial growth factor C (VEGF-C) in normal human tissues. Lymphat. Res. Biol. 4 (2006) 73-82
13. Kiseleva E.P., Krylov A.V., Lyudyno V.I., and Suvorov A.N. Effect of VEGF on mouse thymocyte proliferation and apoptosis in vitro. Bull. Exp. Biol. Med. 139 (2005) 576-579
14. Kostopoulos I., Arapantoni-Dadioti P., and Gogas H. Evaluation of the prognostic value of HER 2 and VEGF in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy. Breast Cancer Res. Treat. 96 (2006) 251-261
15. Ljungberg B.J., Jacobsen J., and Rudolfsson S.H. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. BJU Int. 98 (2006) 661-667
16. Lungu G.F., Li M.L., Xie X., Wang L.V., and Stoica G. In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion. Int. J. Oncol. 30 (2007) 45-54
17. Masood R., Cai J., Zheng T., Smith D.L., Hinton D.R., and Gill P.S. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98 (2001) 1904-1913
18. Miyata Y., Kanda S., Ohba K., Nomata K., Hayashida Y., Eguchi J., Hayashi T., and Kanetake H. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin. Cancer Res. 12 (2006) 800-806
19. Müller S., Grzegorz T., Blum C., Haller C., Anquez V., Kuschert S., Carmeliet P., Augustin H.G., and Rodewald H.R. Gene targeting of VEGF-A in thymus epithelium disrupts thymus blood vessel architecture. PNAS 102 (2005) 10587-10592
20. Ochs A.M., Wong L., and Kakani V. Expression of vascular endothelial growth factor and HER 2/neu in stage II colon cancer and correlation with survival. Clin. Colorectal Cancer 4 (2004) 262-267
21. Ohm J.E., Gabrilovich D.I., Sempowski G.D., Kisseleva E., Parman K.S., Nadaf S., and Carbone D.P. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101 (2003) 4878-4886
22. Papadopoulos P.K., and Thomas C.R. Current chemotherapy options for thymic epithelial neoplasms. Expert Opin. Pharmacother. 6 (2005) 1-7
23. Pufe T., Kurz B., Petersen W., Varoga D., Mentlein R., Kulow S., Lemke A., and Tillmann B. The influence of biomechanical parameters on the expression of VEGF and endostatin in the bone and joint system. Ann. Anat. 187 5-6 (2005) 461-472
24. Raica M., Encica S., Motoc A., Cimpean A.M., Scridon T., and Bârsan M. Structural heterogeneity and immunohistochemical profile of Hassall corpuscles in normal human thymus. Ann. Anat. 188 (2006) 345-352
25. Reinders M.E.J., Sho M., Izava A., Wang P., Mukhopadhyay D., Koss K.E., Geehan C., Luster A.D., Sayegh M.H., and Briscoe D.M. Proinflamatory functions of vascular endothelial growth factor in alloimmunity. J. Clin. Invest. 112 (2003) 1655-1665
26. Rosai J. Histological Typing of Tumours of the Thymus (1999), Springer, Berlin
27. Sasaki H., Yukiue H., Kobayashi Y., Nakashima Y., Moriyama S., Kaji M., Kiriyama M., Fukai I., Yamakawa Y., and Fujii Y. Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms. Surg. Today 31 (2001) 1038-1040
28. Senger D.R., Galli S.J., Dvorak A.M., Perruzzi C.A., Harvey V.S., and Dvorak H.F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascite fluids. Science 219 (1983) 983-985
29. Shifren J.D., Doldi N., Ferrara N., Mesiano S., and Jaffe R.B. In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrinol. Metab. 79 (1994) 316-322
30. Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J. Biochem. Mol. Biol. 39 (2006) 469-478
31. Stalmans I., Lambrecht D., and Desmet F. VEGF: a modifier of the del22q11 (Di George) syndrome?. Nat. Med. 9 (2003) 173-182
32. Strohmeyer D., Strauss F., and Rossing C. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer. Anticancer Res. 24 (2004) 1797-1804
33. Takahashi Y., Akishima-Fukasawa Y., Kobayashi N., Sano T., Kosuge T., Nimura Y., and Hiraoka N. Prognostic value of tumor architecture, tumor-associated vascular characteristics, and expression of angiogenic molecules in pancreatic endocrine tumors. Clin. Cancer Res. 13 (2007) 187-196
34. Tomita M., Matsuzaki Y., Edagawa M., Maeda M., Shimizu T., Hara M., and Onituska T. Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors. J. Thorac Cardiovasc. Surg. 124 (2002) 493-498
35. Watanabe N., Wang Y.H., and Lee H. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in the human thymus. Nature 436 (2005) 1181-1185